SCHEMBL5624488

SCHEMBL5624488

CCCCCN(c1ccc(OC)cc1)S(=O)(=O)c1ccc(OC)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2C9 P11712 1/20 0.60
TSHR P16473 1/20 0.60
CYP2C19 P33261 1/20 0.60
KEAP1 Q14145 2/20 0.59
NFE2L2 Q16236 2/20 0.59
CNR2 P34972 4/20 0.59
BMP1 P13497 1/20 0.57
ALOX5 P09917 3/20 0.55
PTGES O14684 2/20 0.55
ESR1 P03372 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
CAMK2A Q9UQM7 3/20 0.54
NR3C1 P04150 1/20 0.53
PGR P06401 1/20 0.53
LMNA P02545 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
CNR1 P21554 2/20 0.53
CAMK2G Q13555 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5624485 0.95 KEAP1 (0.61) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL5622632 0.89 KEAP1 (0.64) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL20314689 0.89 ESR1 (0.71) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL5622498 0.83 KEAP1 (0.68) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL5623048 0.82 ESR1 (0.78) ALOX5PTGESESR1L3MBTL1
SCHEMBL4827499 0.81 MCHR1 (0.48) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL29028430 0.79 CNR2 (0.56) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL13979922 0.78 CNR2 (0.61) KEAP1CNR2BMP1LMNA
SCHEMBL5622256 0.78 ESR1 (0.68) ALDH1A1CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL6324195 0.78 SMN1; SMN2 (0.65) KEAP1NFE2L2CNR2BMP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021495-A1 SULFONAMIDES AS SELECTIVE ESTROGEN RECEPTOR NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021495-A1 SULFONAMIDES AS SELECTIVE ESTROGEN RECEPTOR ESR1, ESR2, GPER1 ALDH1A1 826/4885CYP3A4 95/4885CYP2C9 414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.